Related Experiment Video
Updated: Jul 29, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Analysis of possible risk predictors in patients with coronavirus disease 2019: a retrospective cohort study
Beatriz Nienkotter1, Marcelo Vier Gambetta1, Franciani Rodrigues da Rocha1
1Centro Universitário para o Desenvolvimento do Alto Vale do Itajaí, Núcleo de Pesquisa em Ciências Médicas: Investigações em Saúde, Faculdade de Medicina - Rio do Sul (SC), Brazil.
Insights
Older age and significant pulmonary involvement predict worse outcomes for hospitalized COVID-19 patients. High-flow oxygen therapy indicates a severe prognosis, while corticosteroid treatment showed benefits in managing coronavirus disease 2019.
Area of Science:
- Infectious Diseases
- Epidemiology
- Clinical Medicine
Background:
- Coronavirus disease 2019 (COVID-19) poses a significant global health challenge.
- Understanding the clinical-epidemiological profile of hospitalized patients is crucial for effective management.
- Tertiary care hospitals play a vital role in managing severe COVID-19 cases.
Purpose of the Study:
- To analyze the clinical-epidemiological characteristics of COVID-19 patients admitted to a tertiary care hospital.
- To identify predictors of adverse outcomes and assess survival rates.
- To evaluate the effectiveness of treatments like corticosteroid therapy.
Main Methods:
- Observational, retrospective cohort study.
- Analysis of medical records of 502 patients hospitalized between April 2020 and December 2021.
- Inclusion of demographic data, comorbidities, laboratory findings, clinical course, and treatment outcomes.
Main Results:
- The study included 502 patients, with a median age of 56 years; 31.7% were over 65.
- Common symptoms included dyspnea and cough; frequent comorbidities were obesity, hypertension, and diabetes.
- Predictors of poor prognosis included age >65, pulmonary involvement >50%, and need for high-flow oxygen therapy. Corticosteroids were widely used (98.4%) with beneficial outcomes.
Conclusions:
- Age over 65 and extensive pulmonary involvement are significant predictors of worse prognosis in COVID-19.
- The requirement for high-flow oxygen therapy indicates a more severe disease course.
- Corticosteroid treatment demonstrated a beneficial effect in the management of hospitalized COVID-19 patients.
Objective:
This study aimed to analyze the clinical-epidemiological profile, possible risk predictors, and outcomes of patients with coronavirus disease 2019 admitted to the ward of a tertiary care hospital in southern Brazil. Specifically, we describe the demographic characteristics, comorbidities, baseline laboratory findings, clinical course, and survival of these patients.
Methods:
This is an observational, retrospective cohort study, performed from January to March 2022, on medical records of patients hospitalized between April 2020 and December 2021 in the coronavirus disease 2019 ward of a tertiary hospital in southern Brazil.
Results:
Data from 502 hospitalized patients were analyzed, of which 60.2% were male, with a median age of 56 years and 31.7% were over 65 years old. The main symptoms presented were dyspnea/respiratory discomfort (69.9%) and cough (63.1%). The most common comorbidities were obesity, systemic arterial hypertension, and diabetes mellitus. A proportion of 55.8% of 493 patients had PaO2/FiO2<300 mmHg in the first examination performed after admission and 46.0% had a neutrophil/lymphocyte ratio>6.8. Oxygen therapy by Venturi mask or mask with reservoir was used in 34.7% of the patients, and non-invasive ventilation was used in 10.0% of the patients. The majority of the patients (98.4%) used corticosteroids, and the outcome of 82.5% of the hospitalized patients was home discharge.
Conclusion:
After analyzing the clinical and epidemiological profile, it can be concluded that age greater than 65 years and pulmonary involvement >50% are predictors of a worse prognosis for coronavirus disease 2019, as is the need for high-flow oxygen therapy. Corticotherapy, however, proved to be beneficial in the treatment of the disease.
More Related Videos
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Single Nucleotide Polymorphisms-SNPs
Relative Risk
Coronary Artery Disease I: Introduction
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Acute Coronary Syndrome III: Diagnostic Studies